• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Prevention of premature discontinuation of dual antiplatelet therapy
Prevention of premature discontinuation of dual antiplatelet therapy

... trends among the aging population, and oral disease risks associated with medications and common systemic diseases. Most patients take multiple medications, many of which have oral complications and drug interactions of significance to dentistry. Medication therapies, oral drug and disease complicat ...
AMERICAN ACADEMY OF PEDIATRICS Uses of Drugs Not
AMERICAN ACADEMY OF PEDIATRICS Uses of Drugs Not

... by mail, phone, or Internet (http://www.fda.gov/ medwatch). The law requires manufacturers to report all adverse experience reports they receive or are aware of (eg, published literature) to the FDA. Promising new uses for approved drugs might best be reported to the drug sponsor to encourage formal ...
Comparison of Drug Approval Process in United States
Comparison of Drug Approval Process in United States

... Pharmaceutical Quality Assurance Group, Department of Pharmaceutics, JSS College of Pharmacy, JSS University, Sri Shivarathreeshwara Nagara, Mysore - 570015, Karnataka, India. Abstract: This topic aims at reviewing the drug filing and different aspects of obtaining United States Food & Drug Administ ...
DRUG
DRUG

... metabolism of a drug when it is absorbed from the gut and delivered to the liver via the portal circulation. • The greater the first-pass effect, the less the agent will reach the systemic circulation when the agent is administered ...
RbpIM2NB9aknDTWGrJxNseAn_oLZef8Uz5SaHBqAcj8LseFq3
RbpIM2NB9aknDTWGrJxNseAn_oLZef8Uz5SaHBqAcj8LseFq3

... 52) A package insert lists a drug dose for a neonate as being 10 mcg/kg/ day. The age range for a neonate is considered to be : a) birth to 1 month b) 1 month to 6 months c) 1 month to 1 year d) birth to 1 week e) 1 year through 5 years ...
Anti Depressants Do you need them?
Anti Depressants Do you need them?

...  The core message of todays lecture is;  People take anti-depressants because they think that will help them to feel better  But psycho-pharmaceutical drugs may not work in the way you expect them to i.e. they may not help us to feel better and may cause major harm in the long run.  Maybe a radi ...
Uppers Downers & All Arounders
Uppers Downers & All Arounders

... – Use has irregular pattern with small impact on person’s life – Same consequences of use can occur as with experimentation ...
Document
Document

... • Epinephrine and isoproterenol are nonselective beta-1 and beta-2 agonists • Albuterol, terbutaline, and salmeterol are selective beta-2 agonists that do not cause excessive cardiac stimulation • Selective beta-2 drugs are preferred for the control of asthma • Epinephrine SC is the drug of choice t ...
dextromethorphan - HNE Health Libraries
dextromethorphan - HNE Health Libraries

... • Acta Neurol Taiwan Effectiveness of Vtamin B12 on diabetic ...
The drugs discussed in this chapter are used to alter an individual`s
The drugs discussed in this chapter are used to alter an individual`s

... Given P0 or PR for sedation in acute psychiatric excitement and acute alcoholic withdrawal Special considerations: Dilute before use; use food to improve taste; avoid contact with plastic; keep away from heat or flame; ...
general_pharmacology
general_pharmacology

... triple distilled and pyrogen free (pyrogen: are bacterial products which cause a rise in body and rigors when injected).  The glass container should be neutral as not react with drug.  The contents are usually liquid but may be in powder form to dissolve immediately before use.  They may be dispe ...
7.4 Drugs as Amines
7.4 Drugs as Amines

... Many drugs (probably 85% of the drugs on the market) contain amine groups covalently bonded to groups that are relatively hydrophobic. Most of these drugs are administered in the ammonium ion form. This accomplishes two objectives. 1) It makes the drug more water soluble (very important if the drug ...
Prescriptions Drugs 101
Prescriptions Drugs 101

... drug that reaches the bloodstream. —  What determines bioavailability? ◦  Physical properties of the drug like its charge, and whether it is water- or fat-soluble ◦  Drug formulation: immediate release or timed release ◦  Drug administered on a full or empty stomach ...
Weighing up the costs of switching AEDs
Weighing up the costs of switching AEDs

... Maintaining health, is a costly business. As consumers we are always looking to save money on that headache, hayfever or flu tablet and generic formulations often provide that saving. Under the Pharmaceutical Benefits Scheme (PBS) the maximum cost for a pharmaceutical benefit item at a pharmacy is g ...
Basic Nursing: Foundations of Skills and Concepts Chapter 24
Basic Nursing: Foundations of Skills and Concepts Chapter 24

... absorption, excretion, or use in the body of one or more nutrients.  Certain foods may increase or decrease the absorption of a drug into the body.  Other foods may alter the chemical actions of drugs, preventing their therapeutic effect on the body. ...
introduction to investigational drugs
introduction to investigational drugs

... To identify what an investigational drug is and its place in clinical trials To learn about the different types of investigational drugs To learn about the different types of clinical trials To learn how investigational drugs are managed at the University of Kentucky Hospital To identify how to acce ...
USMLE I
USMLE I

... efficacious than Drug Y. Efficacy is defined as the maximum effect that can be produced by a drug, regardless of dose. Drug X can only produce a 50% change in resistance, whereas Drug Y can produce a 75% change in resistance. Therefore, Drug X is less efficacious than Drug Y. ...
Chapter 4 - Drugs and the Law
Chapter 4 - Drugs and the Law

...  Food Drug and Cosmetic Act of 1938  Limited OTC drug sales (prior exception was only for ...
powerpoint format
powerpoint format

... or addiction than drugs in the first two schedules and have a currently accepted medical use. • Examples of Schedule III drugs include Anabolic steroids, Codeine, Ketamine, Hydrocodone with Aspirin, and Hydrocodone with Acetaminophen. • Schedule III drugs may be available with a prescription, but no ...
A new international, multicenter study has found that incretin
A new international, multicenter study has found that incretin

... noted the pancreatic cancer risk (but which didn't specifically investigate it) were limited in a number of ways including, small sample sizes, low duration time follow-ups and a low number of specific incretin-based drugs. The findings of this new study suggests that when compared to sulfonylureas, ...
Emergency Pharmacology
Emergency Pharmacology

... prove drug’s safety and to identify tolerable dosages  Phase II – limited controlled evaluation. Designed to test drug’s effect on the specific illness it was designed for. After completion of this phase, a new drug application can be submitted to the FDA. If approved, we move to phase III  Phase ...
Substance abuse in the workplace
Substance abuse in the workplace

... Caffeine was the most used, until more potent stimulants ...
pharmacokinetics - Dr. Brahmbhatt`s Class Handouts
pharmacokinetics - Dr. Brahmbhatt`s Class Handouts

... Period of time after drug administration during which the animal cannot be sent to market for slaughter and the eggs/milk must be discarded ...
PDF file - First Class Login
PDF file - First Class Login

... MAO inhibitors can not be taken with certain foods such as cheese, avocado, and wine because this interaction will raise blood pressure that can cause heart failure and death. Usually, doctors will avoid prescribing MAOI’s for these reasons. These drugs can also be lethal at relatively low dosages, ...
FDA Drug Approval Process
FDA Drug Approval Process

... We don’t do clinical trials in a random sample of the population. We try to make sure people have the disease we’re studying (entry criteria), have stable disease with stable measurements (lead in periods), do not respond too well to placebo (placebo lead in periods), have disease of some defined se ...
< 1 ... 117 118 119 120 121 122 123 124 125 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report